We deliver world-leading clinical trials of innovative new treatments and diagnostic tools. 天发娱乐棋牌_天发娱乐APP-官网|下载 trials directly influence routine clinical practice for the benefit of patients.
We work at the forefront of innovative clinical research, taking discoveries from the laboratory into the clinic to provide the treatments and medical interventions of the future. 天发娱乐棋牌_天发娱乐APP-官网|下载 team has expertise in the design, conduct and analysis of multi-centre, interventional clinical trials and other well-designed studies. We work in partnership with investigators to deliver high-quality trials that will directly influence routine clinical practice. We are a UK Clinical Research Collaboration registered CTU that receives core funding from Cancer Research
with additional funding from the NIHR 天发娱乐棋牌_天发娱乐APP-官网|下载 Biomedical Research Centre (BRC) and is part of the South Central NIHR Research Support Service (RSS).
天发娱乐棋牌_天发娱乐APP-官网|下载 research remit is to create change in the NHS for the benefit of patients. We do this by creating robust evidence via randomised trials and well-designed studies.
My research focuses on novel treatment options for cancer. This includes precision medicine approaches for bladder and prostate cancers, mechanisms of cancer therapy resistance, and epigenetic therapeutics.
I work for the National Institute for Health and Care Research, providing clinical and scientific expertise to its funding programmes, and I’m responsible for development and delivery of non-cancer clinical trials at SCTU.
Mail Point 131, 天发娱乐棋牌_天发娱乐APP-官网|下载 General Hospital, Tremona Road, 天发娱乐棋牌_天发娱乐APP-官网|下载, Hampshire SO16 6YD
View in Google Maps
